Testing effectiveness (Phase 2)WithdrawnNCT04675450
What this trial is testing
NBP in Women With Metastatic Breast Cancer to Prevent Nab-paclitaxel Induced Toxic Neuropathy
Who this might be right for
Breast CancerPeripheral Neuropathy
Conjupro Biotherapeutics, Inc.